Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for the Targeted Treatment of Bullous Pemphigoid (BP)
If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...
Healio23d
Dupilumab does not desensitize children with peanut allergy
injection site urticaria and headache. “The study's findings contribute to our understanding of the potential role of dupilumab in managing peanut allergy and highlight the need for further ...
Hosted on MSN4mon
FDA Approves Dupixent Injections For People Struggling With COPD Symptoms
The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) injections as an add-on therapy for adults with chronic obstructive pulmonary disease (COPD) who continue to struggle ...
Healio12d
Top in allergy/asthma: Dupilumab ineffective for peanut desensitization; asthma blood test
Fewer than 10% of children or adolescents with peanut allergy passed a desnsitiaztion food challenge after receiving dupilumab for 24 weeks. Image: Adobe Stock “The impact of the findings for ...